Gaviscon duo tab o smaku miemti

Leaflet attached to the packaging: patient information

Gaviscon duo tab mint flavor

250 mg + 106.5 mg + 187.5 mg, chewable tablets

Sodium alginate + Sodium hydrogen carbonate + Calcium carbonate

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

Read the leaflet carefully before using the medicine, as it contains important information for the patient.

This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist.

• Keep this leaflet, you may need to read it again.
• If you need advice or additional information, consult a pharmacist.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor or pharmacist. See section 4.
• If after 7 days there is no improvement or the patient feels worse, they should contact their doctor.

Table of contents of the leaflet:

• 1. What is Gaviscon duo tab mint flavor and what is it used for
• 2. Important information before using Gaviscon duo tab mint flavor
• 3. How to use Gaviscon duo tab mint flavor
• 4. Possible side effects
• 5. How to store Gaviscon duo tab mint flavor
• 6. Package contents and other information

1. What is Gaviscon duo tab mint flavor and what is it used for

Gaviscon duo tab mint flavor is a combination of alginate and two acid-neutralizing agents (calcium carbonate and sodium hydrogen carbonate) that work in two ways:

• 1. Creating a protective barrier over the stomach contents, which helps to relieve heartburn (the soothing effect can last up to 4 hours).
• 2. Neutralizing excess stomach acid to relieve pain and discomfort.

This medicine is used to treat symptoms of acid reflux, such as heartburn, acid regurgitation, and indigestion, for example after meals or during pregnancy.

2. Important information before using Gaviscon duo tab mint flavor

When not to use this medicine

• if the patient is allergic to the active substances or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Before taking Gaviscon duo tab mint flavor, the patient should discuss it with their doctor or pharmacist:

• if the patient has or has had a serious kidney or heart disease, as some salts may affect these diseases (the patient should discuss the salt content of the medicine with their doctor).
• if the patient has previously been diagnosed with intolerance to some sugars.
• if the patient has severe kidney impairment.
• if the patient has electrolyte disturbances causing low phosphate levelsin the blood (hypophosphatemia).
• If the patient has reduced stomach acid, the medicine may be less effective.

Like other acid-neutralizing medicines, taking this medicine may mask the symptoms of other, more serious diseases.

If symptoms persist for more than 7 days, the patient should consult their doctor.

Children

This medicine should not be given to children under 12 years of age. There is a risk of increased sodium levels in the blood (hypernatremia) in children with kidney function disorders or stomach and intestinal inflammation.

Gaviscon duo tab mint flavor and other medicines

The patient should not take this medicine within 2 hours of taking other oral medicines, as it may interfere with their action. This is especially important if the patient is taking antihistamines, antibiotics (tetracyclines and quinolones, such as norfloxacin), iron preparations, thyroid hormones, antifungal medicines (such as ketoconazole), digoxin, and beta-adrenolytics (used in heart diseases), neuroleptics (used in mental illnesses), thyroxine, chloroquine (used in malaria), bisphosphonates (used in osteoporosis), and estramustine (used in prostate cancer). The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.

Pregnancy, breastfeeding, and fertility

The patient can take this medicine if they are pregnant, breastfeeding, or planning to have a child. As with all medicines, the duration of treatment should be as short as possible.

Important information about some ingredients of this medicine

This medicine contains 5.86 mg of aspartame (E951) in each chewable tablet. Aspartame is a source of phenylalanine. It may be harmful if the patient has phenylketonuria, a rare genetic disorder in which phenylalanine accumulates, as the body cannot remove it properly. The chewable tablets contain azorubine (E122), which may cause an allergic reaction. The medicine contains 223.7 mg (9.728 mmol) of sodium in a dose of four chewable tablets. The maximum recommended daily dose of this medicine contains 895 mg of sodium (found in salt). This corresponds to 44.75% of the recommended maximum daily sodium intake for an adult. If the patient takes this medicine daily for a long time, they should talk to their pharmacist or doctor, especially if they have been advised to follow a low-sodium diet. The medicine contains 300 mg (7.5 mmol) of calcium in a dose of four chewable tablets. Before taking this medicine, the patient should talk to their doctor if they have kidney stones or high calcium levels in the blood. If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking this medicine.

3. How to use Gaviscon duo tab mint flavor

This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist. Oral administration. Chew thoroughly before swallowing. Adults and adolescents over 12 years:If symptoms occur, take 2 to 4 chewable tablets after meals and before bedtime, up to 4 times a day. Children under 12 years:Not recommended for children under 12 years.

Taking a higher dose of this medicine than recommended

It is unlikely that taking too much of this medicine will harm the patient. However, they may experience bloating and abdominal discomfort. If the symptoms do not go away, the patient should consult their doctor. Missing a dose of this medicine:The patient should not take a double dose to make up for a missed dose. They should continue taking the medicine as before.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. If the patient experiences side effects, they should stop taking the medicine and consult their doctor immediately. Very rarely (may affect up to 1 in 10,000 people), an allergic reaction to the ingredients of the medicine may occur. Symptoms may include abdominal pain, diarrhea, nausea, vomiting, rash, itching, dizziness, facial swelling, lip swelling, tongue swelling, or throat swelling, and difficulty breathing. Taking large amounts of calcium carbonate, an ingredient of this medicine, may cause elevated blood pH (alkalosis), high calcium levels in the blood (hypercalcemia), increased stomach acid production, and constipation. These usually occur after taking higher than recommended doses.

Reporting side effects

If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be collected on the safety of the medicine.

5. How to store Gaviscon duo tab mint flavor

The medicine should be stored out of sight and reach of children. Do not use this medicine after the expiry date stated on the carton and blister after "EXP". The expiry date refers to the last day of the month stated. Do not store above 30°C. Store in the original package to protect from moisture. Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Package contents and other information

What Gaviscon duo tab mint flavor contains

The active substances in each chewable tablet are 250 mg of sodium alginate, 106.5 mg of sodium hydrogen carbonate, and 187.5 mg of calcium carbonate. The other ingredients are: macrogol 20, mannitol type 100, copovidone, peppermint flavor (containing sucrose, maltodextrin, and gum arabic), acesulfame potassium, aspartame (E951), azorubine, aluminum lake (E122), magnesium stearate, xylitol.

What Gaviscon duo tab mint flavor looks like and what the package contains

Flat, round, two-layer chewable tablets with a mint flavor and smell. One layer of the chewable tablet is pink and has a slightly speckled appearance with GDA markings on the surface, and the other layer is white with sword and circle markings. This medicine is available in packages containing 12, 16, 24, 32, 48, 60 chewable tablets. Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Reckitt Benckiser (Poland) S.A., ul. Okunin 1, 05-100 Nowy Dwór Mazowiecki, tel. 0 801 88 88 07

Manufacturer/Importer:

RB NL Brands B.V., Schiphol Boulevard 207, 1118 BH Schiphol, Netherlands

This medicine is authorized in the Member States of the European Economic Area under the following names:

Date of last revision of the leaflet: 12/2024